Navigation Links
Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference
Date:5/5/2008

HOPKINTON, Mass., May 5 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE) today announced that the Company will participate in a panel entitled "Traumatic Brain and Spinal Cord Injury" at the Neurotech Industry Investing & Partnering Conference in Boston, MA, Thursday, May 8, 2008. The session will focus on emerging treatments of major traumatic injuries to the Central Nervous System (CNS). The event is the premier partnering and investing conference for the segment of the healthcare sector focused on neurological technologies.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070608/NEF043LOGO )

About Alseres

Alseres Pharmaceuticals, Inc. (ALSE) is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company maintains a world-class intellectual property position in the field of regenerative therapeutics. The Company's focus is reflected in several important initiatives. CETHRIN, a recombinant- protein-based drug designed to promote nerve repair after acute spinal cord injury, demonstrated positive interim results in a Phase I/IIa clinical trial. The Company's research and pre-clinical programs include, Inosine for the treatment of spinal cord injury and stroke, Oncomodulin for the treatment of ocular injury and disease and research programs directed at a number of regenerative therapies including bone repair. The Company has a robust molecular imaging development program targeting diagnosis of Parkinson's disease and potentially dementia and ADHD. The Company's lead molecular imaging product candidate is ALTROPANE which is in Phase III clinic
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
2. Alseres Pharmaceuticals, Inc. Raises $5 Million
3. Alseres Pharmaceuticals, Inc. to Present at New York Society of Security Analysts Conference
4. Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
5. Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website
6. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
7. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
8. Aida Pharmaceuticals, Inc. Announces New Antibiotic Drug Under Development
9. Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media Agreement
10. Barr Pharmaceuticals, Inc. Executive Bios
11. Jazz Pharmaceuticals, Inc. Announces LUVOX CR Launch Plans and Reports Development Pipeline Progress at Investor Day Presentation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...t from incapacitated to working again, , ...l stimulation of a certain area of the brain may p... say German researchers. , They implanted elect...of 10 people. This area of the brain is part of t... good experiences and puts them in a state of plea...
(Date:11/9/2009)...ewswire-USNewswire/ -- New Mayo Clinic research ha...e dramatically reduces patient hospital stay and... this week at the North Central Section of the Ame... ,, (Logo: http://www.newscom.com/cgi-bin/prn...ional audio and video resources, including excerpt...
(Date:11/9/2009)...form our current campaign finance system ,, WA...s of Congress who noted "no" on health care reform...3 million more in campaign donations from health i...f the legislation to overhaul of the nation,s heal...a coalition of campaign reform groups. ,, "The ...
(Date:11/9/2009)...ital and the University of Florida Proton Therapy ...roton therapy for St. Jude patients. The announcem...dy to evaluate the use of proton therapy for rare .... , Under the clinical protocol, St. Jude will...F Proton Therapy Institute in Jacksonville, Fla. T...
(Date:11/9/2009)...ction industry, respiratory disease, often leading...a major public health concern. Studies led by Deb...ech,s School of Construction, have shown that spec...n reducing the dust that causes these health hazar...nology remains very low. , To find out why, Youn...
Breaking Medicine News(10 mins):Health News:Brain Stimulation May Ease Treatment-Resistant Depression 2Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 2Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 3Health News:'No' Votes on Health Care Bill Received $2.3 Million More from Health Insurance Industry 2Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 3
...-FirstCall/ - In light of Neurochem,Inc.,s (NASDAQ...ompany,announces the departure, effective February... team, Dr. Andreas Orfanos, MBB. Ch, MBA, Executiv...heir,acting as consultants in respect of specific ...
...hodist Mansfield Medical,Center has opened a new S...e growing number of people with sleep disorders. T...p-study suites to evaluate sleep apnea,insomnia, r...disorders,according to the American Academy of Sle...
... peaceful visual environment, ease anxiety of pa...are facilities, WASHINGTON TOWNSHIP, N.J., Feb. 2...em shorter. Stress, tension and anxiety too,often ...ideo,Productions. Engineered in a high-quality DVD...
...cate AIDS Garners Recognition, DALLAS, Feb. 21 E...es are infected with HIV. In an effort to stop the... pastor of The Potter,s House of Dallas,has initia...to Bishop Jakes, presenting him with the Heroes in...
...ons current shot misses, but fall production may ...y News) -- A U.S. Food and Drug Administration pan... flu strains in next year,s batch of flu vaccine, ...h year, and flu vaccine manufacturers need a long ...
...ose discoveries have led to fundamental advances i...pients of two prestigious international prizes off...on and the American Association for Cancer Researc... largest awards in the world offered to cancer res...
Other Medicine News:Health News:Neurochem announces departure of two members of management team 2Health News:New Sleep Diagnostic Center Opens at Methodist Mansfield 2Health News:New Scenic Relaxation Videos Help Reduce Stress, Promote Sense of Calm and Tranquility 2Health News:Bishop T. D. Jakes Receives The Black Aids Institute 2008 Heroes in the Struggle Award 2Health News:FDA Panel OKs 3 New Flu Strains for Next Year's Vaccine 2Health News:FDA Panel OKs 3 New Flu Strains for Next Year's Vaccine 3Health News:AACR's Seventh Annual Landon Awards 2Health News:AACR's Seventh Annual Landon Awards 3Health News:AACR's Seventh Annual Landon Awards 4Health News:AACR's Seventh Annual Landon Awards 5
(Date:11/9/2009)... , PHILADELPHIA, Nov. 9 /PRNewswire-FirstCall...e global specialty biopharmaceutical company, toda...uanfacine) Extended Release Tablets in pharmacies ...ntion-Deficit/Hyperactivity Disorder ( ADHD ) in...a once-daily formulation of guanfacine, is the fir...
(Date:11/9/2009)... , BETHESDA, Md., Nov. 9 /PRNewswire-Asia...aq: CHDX ), a leading independent American provid...the People,s Republic of China, today,announced re...cal 2010, which,ended September 30, 2009. , , ... quarter of fiscal 2010 was $38.1 million, flat on...
(Date:11/9/2009)... , SOUTH SAN FRANCISCO, Calif., Nov. 9 /PRNew... today announced that on November 5, 2009, it rece...asdaq") stating that the Nasdaq Hearing Panel has ... The NASDAQ Global Market subject to the condition...cember 31, 2009, the proposed merger (the "Merger"...
Breaking Medicine Technology:Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 2Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 3Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 4Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 5Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 6Once-Daily INTUNIV(TM) (guanfacine) Extended Release Tablets Now Available in Pharmacies Nationwide 7Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 2Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 3Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 4Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 5Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 6Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 7Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 8Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 9Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 10Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results 11Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 3Blood Sugar Spikes Send Testosterone Levels Down 48816 1Blood Sugar Spikes Send Testosterone Levels Down 48816 2Siemens Makes Innovation Accessible with Comprehensive Molecular Imaging Solutions 48814 1Siemens Makes Innovation Accessible with Comprehensive Molecular Imaging Solutions 48814 2Siemens Makes Innovation Accessible with Comprehensive Molecular Imaging Solutions 48814 3Siemens Makes Innovation Accessible with Comprehensive Molecular Imaging Solutions 48814 4Clinical Study Demonstrates Superior Bioavailability of Jarrow 26apos 3Bs Proprietary QH absorb Formula 48812 1Clinical Study Demonstrates Superior Bioavailability of Jarrow 26apos 3Bs Proprietary QH absorb Formula 48812 2Clinical Study Demonstrates Superior Bioavailability of Jarrow 26apos 3Bs Proprietary QH absorb Formula 48812 3Clinical Study Demonstrates Superior Bioavailability of Jarrow 26apos 3Bs Proprietary QH absorb Formula 48812 4
...Intercell AG (VSE: ICLL) today,announced the execu...rtment of,Health and Human Services (HHS). The ag...or Intercell,s Pandemic Influenza program. , ...ine Patch System that,includes an immunostimulant ...,Pandemic Influenza vaccine (manufactured by Solva...
...Vascular BioTherapeutics, Inc. (OTC Bulletin Board...als in the United States opened for patient enroll... treatment of severe coronary heart disease. The s... Minneapolis MN, and Princeton Baptist Medical Cen...irfield (Ohio) and The Christ Hospital in Cincinna...
Other Medicine Technology:USD 12.5 m Funding for the Development of Intercell's Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS) 2USD 12.5 m Funding for the Development of Intercell's Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS) 3CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial 2
Wide Angle Twin MagNP Direct Ophthalmoscope
... the ultimate CT solution for cardiovascular and w... fastest multislice technology with dedicated clin...uality. It provides the highest performance, in or...ovascular diagnosis by utilizing innovative workfl...
...ceiling height, arm reach, power, cabling and the ...ity accommodates more gas, electric and communicat...nough for every surgical procedure and for emergen...lities, Teletoms are surprisingly easy to maneuver...
...fers you a complete solution to surgical lighting....b's original illumination to the surgical field an... field is clear and color correct with a 31" depth... 4500 Kelvin, giving you accurate tissue rendition...
Medicine Products: